Revolution Medicines AAQS 2025

Revolution Medicines AAQS

Ticker

RVMD

ISIN

US76155X1000

WKN

A2PYWG

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Revolution Medicines has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Revolution Medicines in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

Revolution Medicines Aktienanalyse

What does Revolution Medicines do?

Revolution Medicines Inc is a biotechnology company specializing in the development of cancer medications. It was founded in 2014 in Redwood City, California. The company has received significant investment amounts in recent years and is focused on researching and developing personalized cancer therapies that act on a molecular level. They employ a new method called "in-situ imaging" for faster and more precise identification of treatment options. Revolution Medicines is divided into various areas including research and development of new drugs, collaboration with external partners, and conducting their own testing procedures. Their products include a variety of tailored cancer therapies, with RMC-4630 being one of their most promising therapies for advanced breast cancer. They have more products in development and aim to expand their development opportunities through partnerships with other companies in the cancer research field. This company aims to revolutionize cancer research by developing targeted therapies customized to meet individual patient needs, utilizing innovative methods and technologies. However, they face challenges in understanding and treating the complexity of molecular processes in cancer cells, as well as competition in the field. Overall, Revolution Medicines is a biotechnology company focused on shaping the future of cancer research. Revolution Medicines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Frequently Asked Questions about Revolution Medicines stock

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Revolution Medicines

Our stock analysis for Revolution Medicines Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revolution Medicines Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.